Searchable abstracts of presentations at key conferences in endocrinology

ea0029s54.2 | Vitamin D | ICEECE2012

Vitamin D and primary hyperparathyroidism

Mosekilde L.

The occurrence of vitamin D (vitD) insufficiency (plasma 25OHD<50 nmol/l) and deficiency (25OHD<25 nmol/l) in primary hyperparathyroidism (PHPT) varies worldwide in prevalence, severity and symptoms. Epidemiological studies support that the clinical presentation of PHPT is more severe in patients with coexisting vitD deficiency. Most PHPT patients in Europe only have slightly decreased plasma 25OHD levels compared with gender-, age- and season matched controls, and sev...

ea0079020 | Abstracts | BES2021

HLA-DR4/DR13 in a patient with durvalumab-induced thyroiditis

Filette de , M.K Jeroen , Rop Jonas De , Stephanie Andre , Lynn De Mey , Sandrine Aspeslagh , Rafik Karmali , der Auwera Bart J Van , Bert Bravenboer

Background: Immune checkpoint inhibitors (ICI) targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death protein 1 and its ligand (PD-1/PD-L1) are the current standard-of-care for many advanced cancers (1). This novel therapeutic approach comes with its costs in the form of immune-related adverse events (irAE). The underlying mechanisms are not yet fully understood. We explore the role of HLA in endocrinopathy related to ICI therapy using an interes...

ea0077op5.1 | Bone and Calcium | SFEBES2021

Parathyroid hormone (PTH) of 1.6 pmol/l or more at 6 months is associated with delayed recovery of parathyroid function in post-surgical hypoparathyroidism (PoSH)

Fahad Arshad Muhammad , Dhami Amardass , Quarrell Gillian , Balasubramanian Saba P

Introduction: Post-surgical hypoparathyroidism (PoSH) is common after thyroidectomy. Most cases recover within 6 months, but several require long-term supplementation with calcium and activated vitamin D. When PoSH persists beyond 6 months, it is considered to be ‘long-term’ or ‘permanent’. However, few studies have demonstrated recovery beyond this time period.Aim: Aim of this study is to determine the frequency of late recovery in t...

ea0020p238 | Bone/Calcium | ECE2009

Evaluation of the association between bone turnover markers and OPG/sRANK-L levels in relation with the changes of thyroid function in women with thyroid cancer

Salman Serpil , Aral Ferihan , Boztepe Harika , Colak Nese , Omer Beyhan , Tanakol Refik , Alagol Faruk , Kabut-Uzum Ayse

Aim: Thyroid hormones play an important role in bone remodeling. The aim of the study was to evaluate the changes of bone markers and osteoprotegerin (OPG)/sRANK-L levels during follow-up in a group of patients with thyroid cancer.Material and methods: Twenty euthyroid women with the diagnosis of differentiated thyroid cancer were enrolled to the study (39.25±13.46 years, 6 postmenopausal) before thyroidectomy. Samples were collected before the oper...

ea0019oc27 | Bone and Calcium | SFEBES2009

Adipokines may modify osteoblast wnt-signalling through dickkopf-1, and promote osteoclastogenesis by altering RANK-L and osteoprotegerin signalling in obese children

Dimitri P , Wales J , Bishop N

Introduction: We have recently presented data demonstrating total body and regional bone mass relative to body size is reduced in obese children. Adipokines have been shown to play a role in bone metabolism. We hypothesised that 1) increased bone turnover would be associated with reduced bone mass 2) increased serum leptin would be associated with increased osteoclastogenic factors 3) reduced adiponectin woul...

ea0090p602 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Effect of Origanum vulgare L. essential oil on insulin-induced PI3K/Akt signaling and glucose uptake in human adipocytes treated with palmitic acid

Cerda Alexis , Yuri Gabriela , Villagran Isidora , Muller Andrea , Foerster Claudia , Ormazabal Paulina

Background: Obesity is strongly associated with insulin resistance (IR). IR at the molecular level may be defined as a diminished activation of PI3K/Akt signaling and its related molecules (IRS-1/Akt/AS160) as well as reduced glucose uptake. Subjects with obesity have elevated plasma levels of saturated fatty acids, such as palmitic acid (PA), which triggers insulin signaling disruption in vivo and in vitro. Oregano (Origanum vulgare L.) is a plant u...

ea0079025 | Abstracts | BES2021

Hypoglycemia after initiation of CFTR modulator therapy in a cystic fibrosis patient without diabetes

Joke Vliebergh , Hakan Bor , Yskout Marie , Lieven Dupont , Natalie Lorent , Bleyenbergh Pascal Van , Pieter Gillard , der Schueren Bart Van , Ann Mertens , Chantal Mathieu , Roman Vangoitsenhoven

Background: Cystic fibrosis (CF) is a genetic disorder in which a dysfunctional cystic fibrosis transmembrane regulator (CFTR) chloride channel can result in multimorbidity, including severe respiratory disease and reduced pancreatic exocrine secretion and diabetes. Recently, CFTR modulator therapy, has emerged with the potential of improving respiratory function and remission of diabetes. The effect of CFTR modulator therapy on pancreatic function in patients without preexist...

ea0016p175 | Diabetes and cardiovascular diseases | ECE2008

Long term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes mellitus

Masha Andi , Gigliardi Valentina Ramella , Brocato Loredana , Manzato Enzo , Berchio Arrigo , Massarenti Paola , Settanni Fabio , Bergamini Stefania , Iannone Anna , Martina Valentino

Objective: Reactive oxygen species and nitric oxide (NO) have recently been considered involved in the cardiovascular complications of patients with type 2 diabetes as NO is supposed to loose its physiological beneficial effects, due to the presence of oxygen radicals. For this reason, we tested the effects of L-arginine (ARG) and N-acetylcisteine (NAC) administration with the aim to increase NO physiological production reducing free radical formation.</p...

ea0035oc6.3 | Bone, calcium &amp; vitamin D | ECE2014

Hypoparathyroidism: The burden of illness and impact on patients' personal lives

Clarke Bart , Sanders James , Lagast Hjalmar

Hypoparathyroidism, a rare endocrine disorder of insufficient parathyroid hormone, leads to hypocalcemia and often hyperphosphatemia. The PARADOX study assessed the clinical and personal disease impact from the affected patients’ perspective.Patients ≥18 years and diagnosed ≥6 months ago completed a non-validated, self-reported, web-based survey.Three hundred and seventy-four US adults (mean age, 49 years; women, 8...

ea0038p465 | Thyroid | SFEBES2015

The value of thyroxine absorption test followed by weekly thyroxine administration in determining the cause of persistent hypothyroidism despite high dose L-thyroxine treatment: a case report

Hamdan Khaliq , Rahman Mohammad , Mohan-Babu Priya , Obuobie Kofi

Objective: Most hypothyroid patients require an optimal dose of 1.6–1.8 μg/body weight (kg) of L-thyroxine to restore a normal TSH. Poor response to treatment can be due to malabsorption, drugs interaction and poor compliance. We conducted a test to determine the likely cause of persistent hypothyroidism in a coeliac patient despite taking supraphysiological doses of L-thyroxine (>1000 μg OD).Case...